Blood Clot clinical trials at UC Davis

1 research study open to eligible people

Apixaban for the Acute Treatment of Venous Thromboembolism in Children
open to eligible people ages up to 17 years
To assess the safety and descriptive efficacy of apixaban in pediatric subjects requiring anticoagulation for the treatment of a VTE.
Sacramento, California and other locations

Last updated: October 9, 2024